Scott Disick's Weight Loss Outing Raises Ozempic Concerns

Reality TV star Scott Disick sparks health concerns

by Zain ul Abedin
Scott Disick's Weight Loss Outing Raises Ozempic Concerns
© MEGA/GC Images

Scott Disick was recently spotted stepping out for dinner in New York City, drawing attention to his noticeably slimmer figure, sparking concerns among fans. The reality TV star, Scott Disick, known for his appearances on "Keeping Up with the Kardashians," was seen heading to The Polo Bar in Midtown with his daughter Penelope and youngest son Reign.

Scott Disick, 40, showcased his weight loss in a blue suit paired with a white button-up shirt and black dress shoes, while his hair was neatly styled to the side, accentuating his sharp jawline. Accompanying him, Penelope, 11, sported a white sweater with a brown Louis Vuitton scarf, jeans, sneakers, and a handbag, while Reign, 9, opted for a camouflage sweater, white T-shirt, and jeans.

Health Concerns Surround Disick

Also joining the outing was Scott Disick's on-again, off-again girlfriend Bella Banos, who opted for an all-black ensemble. Speculation surrounding Disick's weight loss surfaced after fans noticed his slimmer frame during a recent outing in Los Angeles with Universal Music Group employee Sarah Bauer.

Many speculated that he may have shed pounds with the help of the popular weight loss drug Ozempic. Disick has previously been candid about his health struggles, revealing during Season 3 of "Keeping Up with the Kardashians" that he gained weight following a 2022 car crash that resulted in a back injury.

He explained to Khloé Kardashian that the crash had a significant impact on his life, including his physical fitness and overall well-being. Fans have expressed their concerns for Disick's health, with many taking to social media platforms to discuss his recent appearance and speculate about his weight loss journey.

As Scott Disick continues to make public appearances, fans remain vigilant, hoping for updates on his well-being and any potential health-related developments.